Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Guerini-Rocco

Showing results (61-70 of 153) with videos related to

Pageof 16
Sort By:
Medical Oncology (Northwood, London, England)|December 7, 2017
IMP3 expression in NSCLC brain metastases demonstrates its role as a prognostic factor in non-neuroendocrine phenotypesAlessandro Del Gobbo, Annamaria Morotti, Anna Eleonora Colombo, et al.
Journal of Clinical Pathology|October 6, 2020
Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: a study of the Italian NGS NetworkCaterina Fumagalli, Elena Guerini-Rocco, Fiamma Buttitta, et al.
Virchows Archiv : an International Journal of Pathology|March 27, 2024
Digital counting of tissue cells for molecular analysis: the QuANTUM pipelineVincenzo L'Imperio, Giorgio Cazzaniga, Mauro Mannino, et al.
Histopathology|November 13, 2023
Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologistsKeith M Kerr, Lukas Bubendorf, Fernando Lopez-Rios, et al.
Human Pathology|January 26, 2024
PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scoresMariia Ivanova, Chiara Frascarelli, Bruna Cerbelli, et al.
Cancers|April 12, 2022
Tumor BRCA Testing in Epithelial Ovarian Cancers: Past and Future-Five-Years' Single-Institution Experience of 762 Consecutive PatientsCaterina Fumagalli, Ilaria Betella, Alessandra Rappa, et al.
Cancer Treatment Reviews|October 21, 2023
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testingKonstantinos Venetis, Francesco Pepe, Carlo Pescia, et al.
Cancers|June 12, 2026
Concordance of Actionable Driver Alterations Between Primary Lung Adenocarcinoma and Paired Thoracic Metastases: A Prospective Next-Generation Sequencing StudyLuca Bertolaccini, Mariano Lombardi, Matteo Chiari, et al.
The Oncologist|June 1, 2024
Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancersCarmen Belli, Luca Boscolo Bielo, Matteo Repetto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
PI3K pathway activation in high-grade ductal carcinoma in situ--implications for progression to invasive breast carcinomaRita A Sakr, Britta Weigelt, Sarat Chandarlapaty, et al.
Pageof 16

Showing results (61-70 of 153) with videos related to

Sort By:
Pageof 16
Medical Oncology (Northwood, London, England)|December 7, 2017
IMP3 expression in NSCLC brain metastases demonstrates its role as a prognostic factor in non-neuroendocrine phenotypesAlessandro Del Gobbo, Annamaria Morotti, Anna Eleonora Colombo, et al.
Journal of Clinical Pathology|October 6, 2020
Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: a study of the Italian NGS NetworkCaterina Fumagalli, Elena Guerini-Rocco, Fiamma Buttitta, et al.
Virchows Archiv : an International Journal of Pathology|March 27, 2024
Digital counting of tissue cells for molecular analysis: the QuANTUM pipelineVincenzo L'Imperio, Giorgio Cazzaniga, Mauro Mannino, et al.
Histopathology|November 13, 2023
Optimizing tissue stewardship in non-small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologistsKeith M Kerr, Lukas Bubendorf, Fernando Lopez-Rios, et al.
Human Pathology|January 26, 2024
PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scoresMariia Ivanova, Chiara Frascarelli, Bruna Cerbelli, et al.
Cancers|April 12, 2022
Tumor BRCA Testing in Epithelial Ovarian Cancers: Past and Future-Five-Years' Single-Institution Experience of 762 Consecutive PatientsCaterina Fumagalli, Ilaria Betella, Alessandra Rappa, et al.
Cancer Treatment Reviews|October 21, 2023
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testingKonstantinos Venetis, Francesco Pepe, Carlo Pescia, et al.
Cancers|June 12, 2026
Concordance of Actionable Driver Alterations Between Primary Lung Adenocarcinoma and Paired Thoracic Metastases: A Prospective Next-Generation Sequencing StudyLuca Bertolaccini, Mariano Lombardi, Matteo Chiari, et al.
The Oncologist|June 1, 2024
Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancersCarmen Belli, Luca Boscolo Bielo, Matteo Repetto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
PI3K pathway activation in high-grade ductal carcinoma in situ--implications for progression to invasive breast carcinomaRita A Sakr, Britta Weigelt, Sarat Chandarlapaty, et al.
Pageof 16